Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Retained Earnings (2017 - 2026)

Kiniksa Pharmaceuticals International filings provide 7 years of Retained Earnings readings, the most recent being -$439.5 million for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 266291.52% to -$439.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$439.5 million, a 266291.52% decrease, with the full-year FY2025 number at -$462.1 million, up 11.32% from a year prior.
  • Retained Earnings hit -$439.5 million in Q1 2026 for Kiniksa Pharmaceuticals International, up from -$462.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $55000.0 in Q1 2023 to a low of -$720.6 million in Q2 2022.
  • Median Retained Earnings over the past 5 years was -$439.5 million (2026), compared with a mean of -$270.3 million.
  • Biggest five-year swings in Retained Earnings: skyrocketed 166.67% in 2022 and later plummeted 51225400.0% in 2024.
  • Kiniksa Pharmaceuticals International's Retained Earnings stood at $44000.0 in 2022, then plummeted by 1086350.0% to -$478.0 million in 2023, then fell by 9.04% to -$521.1 million in 2024, then increased by 11.32% to -$462.1 million in 2025, then increased by 4.89% to -$439.5 million in 2026.
  • The last three reported values for Retained Earnings were -$439.5 million (Q1 2026), -$462.1 million (Q4 2025), and -$476.3 million (Q3 2025) per Business Quant data.